Table of Contents
Editorial
An update comment on the diagnosis and treatment of Parkinson's disease | |
Piu CHAN, Hui DING | 1-3 |
Diagnosis and treatment of restless legs syndrome should be concerned | |
Shengdi CHEN, Sheng CHEN | 4-6 |
Forum of Specialists
Atypical parkinsonian disorders | |
Yue HUANG, Shengdi CHEN, Wenning Gregor, et al | 7-14 |
Parkinson's Disease and Movement Disorders
Pathogenesis and treatment of camptocormia in Parkinson's disease | |
Tianyi RONG, Shengdi CHEN | 15-17 |
Gait disorders: classification, diagnosis and treatment | |
Huiwen GUI, Jun LIU | 18-21 |
Research on progressive supranuclear palsy | |
Yiming LIU, Jiazhen LI | 22-26 |
Advances in idiopathic basal ganglia calcification | |
Yingchun ZHAO | 27-29 |
The molecular mechanisms of Huntington's disease and its advances in therapeutic strategies | |
Yaping YAN, Baorong ZHANG | 30-35 |
Research advances on multiple system atrophy | |
Xianwen CHEN | 36-42 |
Progress in the study of botulinum toxin for the treatment of movement disorders | |
Yingmai YANG, Xinhua WAN | 43-50 |
Surgical therapy for Parkinson's disease | |
Ming SHAO | 51-53 |
Original Articles
Change of olfactory function associated structures in Parkinson's disease: a voxel ⁃ based morphometry study | |
Hui DING, Xiaoli WU, Kaiyuan ZHANG, Fengmei FAN, Chaozhe ZHU, Kuncheng LI, Piu CHAN | 54-59 |
Experimental study on the relationship between levodopa ⁃induced dyskinesia and phosphorylation of ERK in the striatum | |
Lu SONG, Yaping MA, Zhenguo LIU, Maowen BA, Leisi BIAN | 60-64 |
Efficacy of repetitive transcranial magnetic stimulation treatment with MPTP Parkinson's disease mice | |
Mingwei WANG, Quandong WANG, Qiaoyun DONG, Jing QIANG, Qinying MA | 65-70 |
The release of lysosomal Pro⁃cathepsin L of BV⁃2 cells upon lipopolysaccharide stimulation and its toxicity to neurons | |
Hui ZHANG, Guidong LIU, Yue LOU, Qin XIAO, Shengdi CHEN | 71-75 |
Analysis of the expression of normal and mutant full⁃length atrophin⁃1 gene in stable and transient transfected eukaryotic cell line | |
Xin ZHANG, Weihong GU, Guoxiang WANG | 76-81 |
Extraction and purification of tumorigenic Schwann cells in vitro from neurofibromatosis type 2 tissues | |
Wei WANG, Xuejun YANG, Yu LI, Xuetao DONG, Huamin WANG, Haolang MING, Bin ZHANG, Shengping YU | 82-87 |
Clinical analysis of ocular myasthenia gravis | |
Xiaowei MA, Li YANG, Chunsheng YANG, Daqi ZHANG, Hui ZHAI, Yan CHENG | 88-92 |
Clinical characteristics of dopa ⁃ responsive dystonia | |
Wei SONG, Rui HUANG, Bi ZHAO, Zhenzhen ZHENG, Huifang SHANG | 93-95 |
Analysis of clinical manifestations and MRI features in multiple sclerosis involved with spinal cord | |
Xueli SHEN, Xi LU, Simeng ZHANG, Mengyao CUI | 96-98 |
Clinicopathologic Report
Subependymoma: a case report and the review of literatures | |
Hui YANG, Xiaoqun BAO, Changshu KE | 99-103 |
Review
The research status of dopamine and its receptor ligands | |
Wei LI | 104-106 |
This work is licensed under a Creative Commons Attribution 3.0 License.
ISSN: 1672-6731